JenniferElizabethVaughanMD

PubMed

• 60 citations
  Functional neurological disorders in Parkinson disease
  Benjamin D. Wissel, Alok Dwivedi, Aristide Merola, Danielle Chin, Cara Jacob, Andrew P. Duker, Jennifer E. Vaughan, Lilia Lovera, Kathrin LaFaver, Ariel Levy, Anthony ...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2018 Jun 1
• 18 citations
  Tablet-Based Application for Objective Measurement of Motor Fluctuations in Parkinson Disease.
  Benjamin D. Wissel, Georgia Mitsi, Alok Dwivedi, Spyridon Papapetropoulos, Sydney Larkin, José Ricardo López Castellanos, Emily Shanks, Andrew P. Duker, Federico Rodri...> ;Digital Biomarkers. 2018 Jan 9
• 28 citations
  Orthostatic hypotension in Parkinson disease: Impact on health care utilization
  Aristide Merola, Russell P. Sawyer, Carlo Alberto Artusi, Ritika Suri, Zoe Berndt, Jose’ Ricardo Lopez-Castellanos, Jennifer E. Vaughan, Joaquin A. Vizcarra, Alberto R...> ;Parkinsonism & Related Disorders. 2017 Nov 1
• 103 citations
  Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration
  Alberto J. Espay, Gustavo Da Prat, Alok Dwivedi, Federico Rodriguez-Porcel, Jennifer E. Vaughan, Michela Rosso, Johnna Devoto, Andrew P. Duker, Mario Masellis, Charles...> ;Annals of Neurology. 2017 Oct 1
• 14 citations
  MFN2 deletion of exons 7 and 8: founder mutation in the UK population
  Aisling Carr, James M. Polke, Jacob Wilson, Ana L. Pelayo-Negro, Matilde Laura, Tina Nanji, James Holt, Jennifer Vaughan, Julia Rankin, Mary G. Sweeney, Julian Blake, ...> ;Journal of the Peripheral Nervous System. 2015 Jun 1
• 104 citations
  Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease
  Alberto J. Espay, Joseph P. Giuffrida, Robert Chen, Megan Payne, Filomena Mazzella, Emily Dunn, Jennifer E. Vaughan, Andrew P. Duker, Alok Sahay, Sang Jin Kim, Fredy J...> ;Movement Disorders. 2011 Dec 1
• Reply: Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: Need for long-term clinical trials.
  > ;Mov Disord. 2011-06-01
• 9 citations
  Botulinum toxin type A for Levodopa‐induced cervical dyskinesias in Parkinson's disease: Unfavorable risk‐benefit ratio
  Alberto J. Espay, Jennifer E. Vaughan, Rakesh Shukla, Maureen Gartner, Alok Sahay, Fredy J. Revilla, Andrew P. Duker> ;Movement Disorders. 2011 Apr 1
• 33 citations
  Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis
  Alberto J. Espay, Jennifer E. Vaughan, Connie Marras, Rob Fowler, Mark H. Eckman> ;Movement Disorders. 2010 Jul 30
• Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.
  Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M> ;Neuroreport. 1999-02-05
• Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
  Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW> ;Lancet. 1997-10-18
• Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
  Espay, A. J., Dwivedi, A. K., Payne, M., Gaines, L., Vaughan, J. E., Maddux, B. N., Slevin, J. T., Gartner, M., Sahay, A., Revilla, F. J., Duker, A. P., Shukla, R.> ;Neurology. 2011 Apr 5
• Join now to see all